Hemapheresis Market
Hemapheresis Market Size, Share & Trends Analysis Report by Technology (Centrifugation, Membrane Separation, Selective Adsorption) by Product (Hemapheresis Devices, and Hemapheresis Disposables) by Procedure (Photopheresis, Plasmapheresis, Plateletpheresis, Leukapheresis, Erythrocytapheresis, and Others), and By Application (Hematology, Neurology, Renal Disease, and Others) Forecast Period (2025-2035)
Industry Overview
Hemapheresis market was valued at $3.8 billion in 2024 and is projected to reach $8.4 billion by 2035, growing at a CAGR of 7.6% during the forecast period (2025-2035). The market growth is driven by factors like the increasing prevalence of chronic diseases, a rising demand for blood components and plasma-derived medicines, and advancements in technology. Key restraints include the high cost of devices and procedures, limited awareness, and regulatory complexities. The market is also experiencing growth due to a focus on personalized medicine, increased government initiatives, and expanding applications in treating autoimmune and neurological disorders.
Market Dynamics
Increasing Prevalence of Chronic and Autoimmune Diseases
One of the primary drivers of the global apheresis market is the rising prevalence of chronic and autoimmune diseases such as multiple sclerosis, rheumatoid arthritis, and systemic lupus erythematosus. These conditions often require therapeutic apheresis procedures, including plasmapheresis and leukapheresis, to manage symptoms and remove harmful components from the blood. Additionally, the growing incidence of hematological disorders, such as leukemia and lymphoma, has accelerated the need for advanced apheresis technologies. As the global population ages and lifestyle-related disorders rise, healthcare providers are increasingly adopting apheresis-based treatments to improve clinical outcomes and patient survival rates, thereby fueling market growth.
Technological Advancements and Innovation in Hemapheresis Devices
Rapid technological advancements in hemapheresis devices have significantly enhanced the efficiency, safety, and automation of the process. Modern apheresis systems feature improved membrane separation technologies, advanced centrifugation techniques, and real-time monitoring capabilities that ensure precision and reduce procedure time. Moreover, the adoption of single-use disposable kits has minimized the risk of cross-contamination and infection. These innovations have made hemapheresis procedures more cost-effective and accessible across hospitals and plasma collection centers. Leading manufacturers are investing heavily in R&D to develop next-generation automated systems, which are expected to further streamline plasma and cellular component collection, boosting market expansion globally.
Expansion of Plasma Collection Centers and Supportive Regulatory Frameworks
The growing demand for plasma-derived medicinal products such as immunoglobulins, albumin, and coagulation factors is driving the expansion of plasma collection centers worldwide. Governments and private organizations are establishing new donation centers and enhancing donor recruitment programs to meet the increasing plasma supply requirements. Additionally, supportive regulatory frameworks and favorable reimbursement policies in developed countries are promoting the adoption of apheresis technologies in both therapeutic and donor settings. Emerging economies in Asia-Pacific and Latin America are also witnessing rising investments in healthcare infrastructure, contributing to greater accessibility and market penetration of apheresis systems.
Market Segmentation
- Based on the technology, the market is segmented into centrifugation, membrane separation, and selective adsorption.
- Based on the product, the market is segmented into hemapheresis devices, and hemapheresis disposables.
- Based on the procedure, the market is segmented into photopheresis, plasmapheresis, plateletpheresis, leukapheresis, erythrocytapheresis, and others.
- Based on the application, the market is segmented into hematology, neurology, renal disease, and others.
Plasmapheresis led to the Largest Market Share
Among all the segments, plasmapheresis, under the procedure category, is expected to lead the global hemapheresis market with the largest share during the forecast period. Plasmapheresis is the most widely adopted apheresis procedure used for both therapeutic and donor applications, primarily due to its extensive use in treating autoimmune and neurological disorders, as well as for plasma collection in biopharmaceutical manufacturing. The growing demand for plasma-derived medicinal products such as immunoglobulins, coagulation factors, and albumin continues to drive the adoption of plasmapheresis systems across hospitals, clinics, and plasma collection centers globally. Furthermore, the expansion of plasma donation programs and the establishment of new plasma collection centers, particularly in the US, Europe, and emerging Asian economies, are further strengthening the dominance of the plasmapheresis segment in the overall market.
Hemapheresis Devices: A Key Segment in Market Growth
The hemapheresis devices segment is a key driver of market growth, supported by technological advancements and the rising need for efficient, automated blood component separation systems. These devices play a crucial role in both donor and therapeutic apheresis procedures, offering precision, speed, and enhanced safety. Modern hemapheresis devices integrate advanced features such as closed-loop control systems, improved centrifugation and membrane separation modules, and real-time data analytics that ensure accurate separation of plasma, platelets, leukocytes, or red blood cells. Automation in these systems reduces manual intervention and operational errors, thereby improving overall efficiency in clinical settings. The increasing demand for automated and portable hemapheresis machines in hospitals, blood banks, and plasma collection centers has significantly boosted sales.
In addition, the rising adoption of hemapheresis devices in the treatment of chronic diseases like leukemia, multiple sclerosis, and myasthenia gravis, along with their use in regenerative medicine and stem cell therapies, is expanding their clinical applications. Manufacturers such as Fresenius Kabi, Terumo BCT, Haemonetics, and Asahi Kasei Medical are actively investing in R&D to introduce next-generation hemapheresis platforms with enhanced user interfaces, better disposables compatibility, and higher throughput. Furthermore, increasing government initiatives to promote voluntary blood and plasma donation and the expansion of healthcare infrastructure in developing economies are expected to create lucrative opportunities for the hemapheresis devices market.
Regional Outlook
The global hemapheresis market is further divided by region, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
Market Players Outlook
The major companies operating in the global hemapheresis market include Ericsson AB, Huawei Technologies Co., Ltd., Nokia Corp., Samsung Electronics Co., Ltd., ZTE Corp., among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Developments
- In May 2025, BBG Advanced Therapies launched the globe's first mobile leukapheresis center, a self-contained facility for collecting starting materials for cell and gene therapies. The center will support healthcare in over 63,000 square miles, collecting immune cells from cancer patients or community donors. The collected cells are used to create personalized therapies for patients.
The Report Covers
- Market value data analysis of 2024 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global apheresis Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Global Hemapheresis Market Sales Analysis – Technology | Product | Procedure | Application ($ Million)
- Hemapheresis Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Hemapheresis Market Trends
- Market Recommendations
- Porter's Five Forces Analysis for the Hemapheresis Market
- Competitive Rivalry
- Threat of New Entrants
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Market Determinants
- Market Drivers
- Drivers For Global Hemapheresis Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Global Hemapheresis Market: Impact Analysis
- Market Opportunities
- Opportunities For Global Hemapheresis Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Hemapheresis Market Revenue and Share by Manufacturers
- Hemapheresis Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Asahi Kasei Medical
- Overview
- Product Portfolio
- Financial Analysis (Subject to Data Availability)
- SWOT Analysis
- Business Strategy
- Braun Melsungen AG
- Overview
- Product Portfolio
- Financial Analysis (Subject to Data Availability)
- SWOT Analysis
- Business Strategy
- Fresenius Medical Care
- Overview
- Product Portfolio
- Financial Analysis (Subject to Data Availability)
- SWOT Analysis
- Business Strategy
- Haemonetics Corp.
- Overview
- Product Portfolio
- Financial Analysis (Subject to Data Availability)
- SWOT Analysis
- Business Strategy
- Terumo BCT
- Overview
- Product Portfolio
- Financial Analysis (Subject to Data Availability)
- SWOT Analysis
- Business Strategy
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- Asahi Kasei Medical
- Key Company Analysis
- Global Hemapheresis Market Sales Analysis by Technology ($ Million)
- Centrifugation
- Membrane Separation
- Selective Adsorption
- Global Hemapheresis Market Sales Analysis by Product ($ Million)
- Hemapheresis Devices
- Hemapheresis Disposables
- Global Hemapheresis Market Sales Analysis by Procedure ($ Million)
- Photopheresis
- Plasmapheresis
- Plateletpheresis
- Leukapheresis
- Erythrocytapheresis
- Others
- Global Hemapheresis Market Sales Analysis by Application ($ Million)
- Hematology
- Neurology
- Renal Disease
- Others (Autoimmune Disorder)
- Regional Analysis
- North American Hemapheresis Market Sales Analysis – Technology | Product | Procedure | Application | Country ($ Million)
- Macroeconomic Factors for North America
- United States
- Canada
- European Hemapheresis Market Sales Analysis – Technology | Product | Procedure | Application | Country ($ Million)
- Macroeconomic Factors for Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia-Pacific Hemapheresis Market Sales Analysis – Technology | Product | Procedure | Application | Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- Rest of Asia-Pacific
- Rest of the World Hemapheresis Market Sales Analysis – Technology | Product | Procedure | Application | Country ($ Million)
- Macroeconomic Factors for the Rest of the World
- Latin America
- Middle East and Africa
- Company Profiles
- Asahi Kasei Medical Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Braun Melsungen AG.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Baxter International Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Becton, Dickinson and Company (BD)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Cerus Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Fresenius SE & Co. KGaA / Fresenius Medical Care / Fresenius Kabi
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Haemonetics Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- HemaCare Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Kaneka Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Kawasumi Laboratories (SB-Kawasumi / Sumitomo Bakelite)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Macopharma SA
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Medica S.p.A. (Medica)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Miltenyi Biotec
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Nikkiso Co., Ltd. (NIKKISO)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Nipro Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- NxStage
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Otsuka Holdings / JIMRO
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Therakos, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Mallinckrodt plc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Ceramics
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Asahi Kasei Medical Co., Ltd.
1. Global Hemapheresis Market Research and Analysis by Technology, 2024–2035 ($ Million)
2. Global Centrifugation Hemapheresis Market Research and Analysis by Region, 2024–2035 ($ Million)
3. Global Membrane Separation Hemapheresis Market Research and Analysis by Region, 2024–2035 ($ Million)
4. Global Selective Adsorption Hemapheresis Market Research and Analysis by Region, 2024–2035 ($ Million)
5. Global Hemapheresis Market Research and Analysis by Product, 2024–2035 ($ Million)
6. Global Hemapheresis Devices Market Research and Analysis by Region, 2024–2035 ($ Million)
7. Global Hemapheresis Disposables Market Research and Analysis by Region, 2024–2035 ($ Million)
8. Global Hemapheresis Market Research and Analysis by Procedure, 2024–2035 ($ Million)
9. Global Photopheresis In Hemapheresis Market Research and Analysis by Region, 2024–2035 ($ Million)
10. Global Plasmapheresis In Hemapheresis Market Research and Analysis by Region, 2024–2035 ($ Million)
11. Global Plateletpheresis In Hemapheresis Market Research and Analysis by Region, 2024–2035 ($ Million)
12. Global Leukapheresis In Hemapheresis Market Research and Analysis by Region, 2024–2035 ($ Million)
13. Global Erythrocytapheresis In Hemapheresis Market Research and Analysis by Region, 2024–2035 ($ Million)
14. Global Other Procedure Hemapheresis Market Research and Analysis by Region, 2024–2035 ($ Million)
15. Global Hemapheresis Market Research and Analysis by Application, 2024–2035 ($ Million)
16. Global Hemapheresis In Hematology Market Research and Analysis by Region, 2024–2035 ($ Million)
17. Global Hemapheresis In Neurology Market Research and Analysis by Region, 2024–2035 ($ Million)
18. Global Hemapheresis In Renal Disease Market Research and Analysis by Region, 2024–2035 ($ Million)
19. Global Hemapheresis In Other Application Market Research and Analysis by Region, 2024–2035 ($ Million)
20. Global Hemapheresis Market Research and Analysis by Region, 2024–2035 ($ Million)
21. North American Hemapheresis Market Research and Analysis by Country, 2024–2035 ($ Million)
22. North American Hemapheresis Market Research and Analysis by Technology, 2024–2035 ($ Million)
23. North American Hemapheresis Market Research and Analysis by Product, 2024–2035 ($ Million)
24. North American Hemapheresis Market Research and Analysis by Procedure, 2024–2035 ($ Million)
25. North American Hemapheresis Market Research and Analysis by Application, 2024–2035 ($ Million)
26. European Hemapheresis Market Research and Analysis by Country, 2024–2035 ($ Million)
27. European Hemapheresis Market Research and Analysis by Technology, 2024–2035 ($ Million)
28. European Hemapheresis Market Research and Analysis by Product, 2024–2035 ($ Million)
29. European Hemapheresis Market Research and Analysis by Procedure, 2024–2035 ($ Million)
30. European Hemapheresis Market Research and Analysis by Application, 2024–2035 ($ Million)
31. Asia-Pacific Hemapheresis Market Research and Analysis by Country, 2024–2035 ($ Million)
32. Asia-Pacific Hemapheresis Market Research and Analysis by Technology, 2024–2035 ($ Million)
33. Asia-Pacific Hemapheresis Market Research and Analysis by Product, 2024–2035 ($ Million)
34. Asia-Pacific Hemapheresis Market Research and Analysis by Procedure, 2024–2035 ($ Million)
35. Asia-Pacific Hemapheresis Market Research and Analysis by Application, 2024–2035 ($ Million)
36. Rest of the World Hemapheresis Market Research and Analysis by Region, 2024–2035 ($ Million)
37. Rest of the World Hemapheresis Market Research and Analysis by Technology, 2024–2035 ($ Million)
38. Rest of the World Hemapheresis Market Research and Analysis by Product, 2024–2035 ($ Million)
39. Rest of the World Hemapheresis Market Research and Analysis by Procedure, 2024–2035 ($ Million)
40. Rest of the World Hemapheresis Market Research and Analysis by Application, 2024–2035 ($ Million)
1. Global Hemapheresis Market Share by Technology, 2024 vs 2035 (%)
2. Global Centrifugation Hemapheresis Market Share by Region, 2024 vs 2035 (%)
3. Global Membrane Separation Hemapheresis Market Share by Region, 2024 vs 2035 (%)
4. Global Selective Adsorption Hemapheresis Market Share by Region, 2024 vs 2035 (%)
5. Global Hemapheresis Market Share by Product, 2024 vs 2035 (%)
6. Global Hemapheresis Devices Market Share by Region, 2024 vs 2035 (%)
7. Global Hemapheresis Disposables Market Share by Region, 2024 vs 2035 (%)
8. Global Hemapheresis Market Share by Procedure, 2024 vs 2035 (%)
9. Global Photopheresis in Hemapheresis Market Share by Region, 2024 vs 2035 (%)
10. Global Plasmapheresis in Hemapheresis Market Share by Region, 2024 vs 2035 (%)
11. Global Plateletpheresis in Hemapheresis Market Share by Region, 2024 vs 2035 (%)
12. Global Leukapheresis in Hemapheresis Market Share by Region, 2024 vs 2035 (%)
13. Global Erythrocytapheresis in Hemapheresis Market Share by Region, 2024 vs 2035 (%)
14. Global Other Procedure Hemapheresis Market Share by Region, 2024 vs 2035 (%)
15. Global Hemapheresis Market Share by Application, 2024 vs 2035 (%)
16. Global Hemapheresis in Hematology Market Share by Region, 2024 vs 2035 (%)
17. Global Hemapheresis in Neurology Market Share by Region, 2024 vs 2035 (%)
18. Global Hemapheresis in Renal Disease Market Share by Region, 2024 vs 2035 (%)
19. Global Hemapheresis in Other Application Market Share by Region, 2024 vs 2035 (%)
20. Global Hemapheresis Market Share by Region, 2024 Vs 2035 (%)
21. US Hemapheresis Market Size, 2024–2035 ($ Million)
22. Canada Hemapheresis Market Size, 2024–2035 ($ Million)
23. UK Hemapheresis Market Size, 2024–2035 ($ Million)
24. France Hemapheresis Market Size, 2024–2035 ($ Million)
25. Germany Hemapheresis Market Size, 2024–2035 ($ Million)
26. Italy Hemapheresis Market Size, 2024–2035 ($ Million)
27. Spain Hemapheresis Market Size, 2024–2035 ($ Million)
28. Russia Hemapheresis Market Size, 2024–2035 ($ Million)
29. Rest of Europe Hemapheresis Market Size, 2024–2035 ($ Million)
30. India Hemapheresis Market Size, 2024–2035 ($ Million)
31. China Hemapheresis Market Size, 2024–2035 ($ Million)
32. Japan Hemapheresis Market Size, 2024–2035 ($ Million)
33. South Korea Hemapheresis Market Size, 2024–2035 ($ Million)
34. Australia and New Zealand Hemapheresis Market Size, 2024–2035 ($ Million)
35. ASEAN Economies Hemapheresis Market Size, 2024–2035 ($ Million)
36. Rest of Asia-Pacific Hemapheresis Market Size, 2024–2035 ($ Million)
37. Latin America Hemapheresis Market Size, 2024–2035 ($ Million)
38. Middle East and Africa Hemapheresis Market Size, 2024–2035 ($ Million)
- Printable version
- No restriction to number of user within the company
Contact Sales
FAQS
The size of the Hemapheresis Market in 2024 is estimated to be around $3.8B.
North America holds the largest share in the Hemapheresis Market, driven by advanced healthcare infrastructure, high prevalence of blood disorders, and growing adoption of apheresis procedures.
Leading players in the Hemapheresis Market include Ericsson AB, Huawei Technologies Co., Ltd., Nokia Corp., Samsung Electronics Co., Ltd., ZTE Corp., among others.
Hemapheresis Market is expected to grow at a CAGR of 7.6% from 2025 to 2035.
The Hemapheresis Market growth is driven by increasing demand for blood components, rising prevalence of chronic diseases, and advancements in apheresis technology and healthcare infrastructure.
